Synfini
Synfini provides an AI-powered drug discovery platform that supports the full chemistry workflow—from molecular design through synthesis, testing, analysis, and data management. Its suite includes SynPlan for project planning and tracking, SynDesign for generating optimized molecules with minimal data, SynRoute for AI-assisted synthesis pathway planning, SynBuild for automated compound production, and SynDB as a centralized reaction and molecular data repository. The platform enables scientists to collaborate seamlessly, customize workflows, and accelerate hit-to-lead and lead optimization stages with efficiency and precision. Synfini also engages in partnerships with biotech firms like Multispan and O₂nix Bio to apply its integrated design-make-test-analyze system to challenging targets such as GPCRs and cancer‑related enzymes.
Domain
synfini.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
1-10
Last Funding
$8.9M
Founded
2022
Tech Stack (35 technologies)
Frequently Asked Questions
What technologies does Synfini use?+
Synfini uses 35 technologies including Contact Form 7, Elementor, Google Analytics.
What industry is Synfini in?+
Synfini operates in the Artificial Intelligence (AI) industry.
Where is Synfini based?+
Synfini is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026